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Infection and septic complications in burn patients can be monitored by pro-
calcitonin (PCT) and neopterin plasma values. The aim of the study was to investi-
gate serum neopterin and PCT levels with WBC (white blood cell) and CRP (C-re-
active protein) levels in patient group (PG) and healthy control group (HCG) and to 
investigate the relationship of these markers with burn wound infections (BWI). 
As the PG, 23 patients between 0–12 ages and up to 30% Total Body Surface Area 
(TBSA) burned and 15 HCG were included. PCT, neopterin, WBC, and CRP results 
on the fi rst, the seventh, the fourteenth and the 21st day have been compared. During 
the follow-up period, 11 patients with BWI and 12 patients without BWI were clas-
sifi ed as infected and non-infected patients, respectively. PCT and neopterin levels 
were detected higher in patients with BWI but no signifi cant difference were present. 
Also, PCT and neopterin levels within the fi rst 24 hours following the burn were 
detected higher in PG than HCG. CRP and WBC levels were detected high due to 
burn trauma. PCT and neopterin levels were increased in patients with BWI. PCT 
levels were increased during the pre-infectious period, while neopterin levels in-
creased during the post-infectious period.
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Introduction
The prominent causes of mortality in burn patients are burn shock, respira-
tory failure and septic complications that develop in the subsequent days [1]. Im-
mune defi ciency and late-onset sepsis continue to be an important problem and 
immunological anomalies that develop in the period following the burn are sug-
gested to be responsible for this condition [2, 3].
Neopterin is regarded as a non-specifi c biochemical marker of stimulated 
cellular immune response [4, 5]. Neopterin levels are observed to increase in 
conditions such as viral infections, intracellular pathogens, autoimmune diseas-
es, infl ammatory diseases, allograft rejection, or malignant diseases [6]. It has 
been reported that the release of neopterin starts 3 days before the T-cell prolif-
eration reaches its peak and the increase in neopterin levels may be observed one 
week before the specifi c antibody production [7]. Previous studies have shown 
that the burn trauma activates T-lymphocyte-macrophage interaction and leads 
to an increase in neopterin levels in the majority of burn patients compared to 
healthy individuals [3, 6].
Procalcitonin (PCT) is normally synthesized in the thyroid gland and dur-
ing bacterial or fungal infections [8, 9]. PCT has been shown to be a useful mark-
er of sepsis in adult patient population in the intensive care units and emergency 
patients with infection [10, 11]. In healthy individuals, the normal serum PCT 
values are below 0.05 ng/mL. It has been reported to increase to <0.5 ng/mL in 
case of local infections; to the values between 0.5–2 ng/mL in probable systemic 
infection, to 2–10 ng/mL in sepsis, and to the levels >10 ng/mL in severe sepsis 
[12]. Recent studies demonstrated that it is possible to detect infection and sep-
tic complications in burn patients by monitoring the PCT plasma values [8].
White blood cell (WBC), C-reactive protein (CRP), sedimentation rate, or 
high fever are non-specifi c markers [13]. CRP is regarded as an infection marker, 
especially in acute bacterial infections [14]. Nevertheless, it is known to increase 
in various conditions including burns, trauma, surgery, tissue necrosis, immune-
mediated diseases, and cancer [15, 16].
In the light of these data, an early diagnosis and treatment of burn infec-
tions are of utmost importance to reduce mortality and morbidity rates. The aim 
of this study was to investigate the serum neopterin and PCT levels simultane-
ously with WBC and CRP levels in children aged 0–12 admitted to the burn unit 
of our hospital and to evaluate the relationship of these markers with burn wound 
infections (BWI).
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Material and Methods
Study groups
a) Patient Group (PG): As PG, 23 children (12 girls and 11 boys) who 
were following-up with burn wounds in Burn Unit of Bagcılar Training and Re-
search Hospital between 0–12 years (mean age: 2.48±0.42) were included in this 
methodologically designed study between March 2012–June 2013. The etiology 
of burns involved contact with hot fl uids in 22 patients and fl ame burns in 1 
 patient. Percent burned total body surface area (TBSA) was calculated according 
to the Lund-Browder chart and patients with burns greater than 30% TBSA and 
those requiring intensive care were excluded from the study. The percentage of 
TBSA that was burned in patients varied between 3%–30% (mean TBSA (%): 
13.08%±6.45%) (Table I).
b) Healthy Control Group (HCG): As a HCG, 15 children (6 girls and 
9 boys) between 0–12 years (mean age: 3.20±2.42) who were following-up with 
anatomical deformity and without any burn wounds were included in this study. 
Demographical data were recorded and PG and HCG were matched for age of 
the groups (p>0.05). All patients and their parents were informed about the study 
and they signed consent forms.
Collection of serum samples
Blood samples were collected on the fi rst day of burn, on the seventh, on 
the fourteenth and on the 21st day in the morning without any operation and ad-
Table I. Characteristics of PG and HCG
Characteristics PG HCG
Number of subject 23 15
Gender (male/female) 11/12 9/6
Age (years) (Mean±sd) 2.48±0.42 3.20±2.42
Percent burned TBSA (Mean±sd) 13.08%±6.45% 0
Number of BWI 11 0
Number of septic patients 1 0
Mortality (%) 0 0
PG: Patient Group, HCG: Healty Control Group, Mean±sd: Mean±standart deviation, 
TBSA: Total Body Surface Area, BWI: Burn Wound Infections
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ditional treatment (antibiotic treatment etc.) and serum fractions of blood samples 
were immediately separated and kept at –80 °C until the study.
Other clinical and laboratory procedure
During the treatment and follow-up of the patients, complete blood count 
and biochemistry samples were also routinely collected and quantitative wound 
smear cultures, deep tissue cultures, blood and urine cultures were studied. Phys-
ical fi ndings including fever, tachycardia and wound evaluation results were also 
recorded (Table II).
Besides systemic parameters such as fever, leukocytosis and acute phase 
reactants, local fi ndings including scar formation, discolouring, edema, erythe-
ma, heat increase and sensitivity were also evaluated as burn wound infection 
criteria. Furthermore, in patients with pulmonary, urogenital, otolaryngological, 
ophthalmological etc. burns, possible causes of infection were ruled out. No pro-
phylactic antibiotic treatment was applied who were admitted to our clinics with 
burn wounds. The antibiotic treatment was chosen in the light of physical exami-
nation, laboratory tests and culture results.
Table II. WBC, CRP, TBSA, fever, PCT and neopterin values of patient groups
Infected patients (n = 11)
mean±sd
median (range)



































WBC, CRP, TBSA, fever, PCT and neopterin values of patient groups
Mean±sd: Mean±standart devision, WBC: White blood cell, CRP: C-reactive protein, 
NS: not signifi cant, TBSA: Total Body Surface Area, PCT: Procalcitonin
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Laboratory tests
Measurements of serum PCT and neopterin levels were applied simultane-
ously in a single run to the serum fractions of blood samples which were col-
lected on the fi rst, on the seventh, on the fourteenth and on the 21st day and kept 
–80 °C. The PCT levels of the serum samples were measured using the mono-
clonal immunoluminometric method (B.R.A.H.M.S PCT Sensitive, BRAHM 
Diagnostic GmbH, Berlin, Germany). The method specifi c to the PCT molecule 
uses two separate monoclonal antibodies binding to the calcitonin and catacal-
cin regions. The minimum value detected by this method was 0.1 ng/mL and 
the measuring range was 0.1–500 ng/mL, while the pathological limit was >0.5 
ng/mL [13, 17]. A commercial ELISA kit (Neopterin ELISA, DRG Instruments 
GmbH, Berlin, Germany) was used according to the manufacturer’s instructions 
to quantitatively determine the serum neopterin levels. Internal controls were 
used during the study. We performed the test in single run therefore we do not 
have inter-assay coeffi cient variation (CV). All calibrators and controls tested in 
two wells and our inter assay CV felled into 5.2–9.5% (7.2) range which described 
in product manual. The pathological value was accepted as ng/mL.
Statistical analysis
Fischer’s exact test was used in frequency and percentage comparisons 
 between PG and HCG for biostatistical evaluation of this study results. To com-
pare PG and HCG, we used Mann-Whitney U-test (data normally distributed). 
Quantitative variables were calculated with arithmetical mean±standart devia-
tion and median. p<0.05 was considered signifi cant.
Ethics: This study was approved by the Non-Invasive Clinical Research 
Ethics Committee of Bagcilar Research and Training Hospital (Number: 
 GOKAEK/2012-91, Date: 10 December 2012).
Results
Among the 23 patients enrolled in the study, 11 (47.8%) were clinically 
and bacteriologically observed to have BWI. No BWI was detected clinically or 
bacteriologically in the other 12 patients. In the PG, patients were grouped as 
infected PG with BWI and non-infected PG without BWI (Table II). In quantita-
tive smear cultures, the following infectious agents were detected: Staphylococ-
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cus aureus in six patients, Pseudomonas aeruginosa in two patients, Staphylo-
coccus epidermidis in one patient and Acinetobacter baumanni in one patient.
In one patient, methicillin-resistant S. aureus (MRSA) growth was accom-
panied by a positive cell culture and sepsis. Among the infected PG, the infec-
tion was detected between the fi fth and the fi fteenth day, with a mean value of 
8.5±3.2. A very high signifi cant difference was detected between PG and HCG 
for PCT and neopterin positivity (p<0.0001, p<0.0001, respectively). Serum 
PCT levels of infected and non-infected PG were detected as 1.66±5.1 ng/mL, 
0.24±0.24 ng/mL, respectively. Although, statistically signifi cant difference be-
tween infected and non-infected PG for PCT levels was not detected, but PCT 
serum level was found higher in infected than in non-infected PG.
Neopterin levels were detected as 7.3±9.2 ng/mL and 5.7±2.8 ng/mL in in-
fected and non-infected PG, respectively. Although, statistically signifi cant dif-
ference between them for serum neopterin levels was not detected, but it was 
found higher in infected than in non-infected PG.
We also compared the classic infection indicators; WBC and CRP in this 
study. Although, no statistically signifi cant difference was detected between in-
fected and non-infected PG for WBC and CRP levels (p>0.05), both of them were 
detected higher in infected PG than non-infected PG.
Figure 1. Mean values of neopterin and PCT in patients who developed burn wound infections 
and patients without burn wound infections
 Mean neopterin values of patients who developed burn wound infections
 Mean neopterin values of patients without burn wound infections
 Mean PCT values of patients who developed burn wound infections
 Mean PCT values of patients without burn wound infections
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Mean percent burned TBSA 14.36%±6.51% and 8.83%±6.45% in infected 
and non-infected PG, respectively. A statistically signifi cant difference was detect-
ed between infection and percentage of TBSA that was burned (p<0.039) (Table II).
Mean values of neopterin and PCT of patients who develope BWI and oth-
er patients only with burn wounds over 21 days period were shown in Figure 1.
Discussion
BWI and associated bacterial sepsis is the major cause of mortality and 
morbidity [18]. An early diagnosis of septic complications and the appropriate 
antibiotic treatment is of utmost important in order to increase the survival rates 
of burn patients [19]. In limited numbers of pediatric studies, Neely et al. [20] 
indicated that PCT had a sensitivity of 42% for early diagnosis of sepsis in 20 
children with burns. Pourakbari et al. [21] concluded that rapid PCT test was 
 superior to neopterin for anticipating bacterial infection in pediatric patients 
with bacterial infection. Mann et al. [8] indicated that PCT may be helpful to 
 diagnose sepsis. Systemic bacterial infections cause marked PCT elevation. 
For example, E. coli endotoxin induces TNF-α and IL-6 followed by an in-
crease of PCT [22]. Budkevich et al. [23] suggested the rise in their PCT levels 
may be related with bacterial complications. Barati et al. [13] studied with 60 
burn patients with and without infection. They detected a signifi cantly higher 
PCT level in the infected group as in our one patient with sepsis and elevated 
PCT level (5.19 ng/mL).
In this study, we detected a very highly signifi cant difference between PG 
and HCG for PCT positivity (p<0.0001). Among patients with and without 
BWI, the mean PCT value was 1.66±5.1 ng/mL and 0.24±0.24 ng/mL, respec-
tively with no statistically signifi cant difference. According to the Carsin et al. 
[24] serum PCT levels were increased during the fi rst hours following burn and 
rapidly stabilised and they concluded that PCT was a useful marker for determi-
nation of the course of patients with burns following burn. But, other investiga-
tors suggested that PCT may be a useful marker for the diagnosis of severe 
 infectious complications after burn [17, 20, 22, 25, 26]. Our results were in con-
cordance with the results of Lavrentieva et al. [19] and Barati et al. [13]. PCT 
levels of our PG on day 1 were at local infection levels (0.5 ng/mL) due to the 
burn trauma. Considering the mean time point (on day 8) the infection was de-
tected, PCT values of the infected PG were increased during the preinfectious 
period, showing a tendency to diminish later. The decrease of PCT levels in the 
subsequent days may be associated with the treatment response infl uencing 
PCT levels. We are of the opinion that PCT is an auxiliary marker of diagnosis.
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Neopterin levels were found to increase in burn injuries and a signifi cant 
elevation in neopterin levels was not seen within 24 hours post-burn. The possi-
ble reason might be due to the late appearance of inducer interferon-gamma [7]. 
We detected a very high signifi cant difference between PG and HCG for neop-
terin positivity (p<0.0001). Within the fi rst 24 hours following the burn damage, 
the mean neopterin level was 5.8±3.2 ng/mL while neopterin level in HCG was 
2.5±0.2 ng/mL. These results suggested that the serum neopterin levels may have 
been increased in burn patients even in the absence of any infection. The mean 
neopterin value of the infected PG was 7.3±9.2 ng/mL in comparison to 5.7±2.8 
ng/mL of non-infected PG. Also, considering day 8, as the infection detection 
time, neopterin levels of the infected PG were found to decrease during the pre-
infectious period, only to increase in the postinfectious period. We also observed, 
neopterin levels were fl uctuated as an increase after the burn trauma, and a de-
crease in the subsequent period, and another increase after the infection. In our 
only sepsis case, initially neopterin levels were increased to 5.8 ng/mL level and 
decreased to 3.5 ng/mL during the therapy. Yao et al. [3] detected increased ne-
opterin levels in most patients on the day of 3 post-burn. Grabosch and Rokos [6] 
detected initially neopterin levels of 22 patients with burn injuries in the normal 
range. After fi rst week, they were increased signifi cantly thereafter. They sug-
gested that elevated neopterin levels could not be attributed either to the burn it-
self or to the later events, the cellular immune system was shown to be highly 
activated. Our results were in concordance with the results of Yao et al. [3], Gra-
bosch and Rokos [6]. Balogh et al. [2] detected a continuous increase in neopterin 
levels of 21 patients with burn until day 10, then a fl uctuation for several weeks. 
They concluded that low neopterin levels in the presence of bacteraemia may 
have been caused by deleterious impairment of immune functions. Our results 
were in accordance with their results.
As a conclusion, although, no statistically signifi cant difference was de-
tected between PG who developed BWI and PG without BWI, it was detected 
that PCT and neopterin levels were increased in PG who developed BWI. The 
PCT levels were observed to increase during the pre-infectious period, while the 
neopterin levels were found to increase during the post-infectious period.
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